Since the direct inhibition of GR has not provided the desired outcome, it becomes crucial to investigate the mechanisms of GR signaling in antiandrogen resistance, with the focus on restricting GR signaling in the cancer while retaining the beneficial effects of glucocorticoids at a system-wide level (5). The gene discussed is NR3C1; the disease is cancer.